Alcohol Breathalyzer and Drug Testing Equipment Market

A breath analyzer is also known as a ‘Breathalyzer’. It is a portable device used by the regulatory authorities across the world to identify if suspect has consumed alcohol above the permitted limits. In emerging and developed countries such as U.S., India, China, government are taking initiatives and enforcing safety laws related work safety issues. According to the Centers for Diseases and Prevention reports published in 2016, excessive alcohol use leads to around 88,000 death in the U.S. each year. Many organizations are now installing breathalyzer in their premises to keep a check on loss of work place productivity due to excessive drinking. Drug testing involves checking for substance use in people who do not necessarily have any symptoms of intoxication or a substance-related disorder. It may be done systematically or randomly in certain groups of people such as students, athletes, and prisoners. A drug test looks for signs of one or more illegal or prescription drugs in a sample of urine (pee), blood, saliva (spit), hair, or sweat. The purpose of a drug test is to look for drug use and misuse, which includes: • Using any illegal drugs, such as cocaine or club drugs • Misusing prescription medicines, which means taking prescription medicines in a different way or for a different purpose than one’s provider prescribed. Examples of drug misuse include using a prescription pain reliever to relax or taking someone else's prescription. A drug test can check for a single drug or for a group of drugs in your body. Drug tests commonly test for: • Alcohol • Amphetamines, including methamphetamine • Barbiturates, such as phenobarbital and secobarbital • Benzodiazepines, such as alprazolam or clonazepam • Cocaine • Marijuana (THC) • Opioids and opiates, such as heroin, codeine, oxycodone, morphine, hydrocodone, and fentanyl • Phencyclidine (PCP) • Steroids Market Dynamics The rise in government programs and initiatives to control the accidents due to drink and drive situation is expected to drive the global alcohol breathalyzer and drug testing equipment. For instance, in August 2021, The Driver Alcohol Detection System for Safety (DADSS) Program started researching a first-of-its-kind technology that holds the greatest potential had to reverse testing of alcohol drink and drive trend. The technology will automatically detect when a driver is intoxicated with a blood alcohol concentration (BAC) at or above 0.08% — the legal limit in all 50 states except Utah — and prevent the car from moving. Once it has met rigorous performance standards, it will be voluntarily offered as a safety option in new vehicles — like automatic braking, lane departure warning and other advanced driver assist vehicle technologies. Furthermore, in 2021, the Driver Alcohol Detection System for Safety (DADSS) Program announced the first-generation system equipped with the breath technology will be made available for open licensing in fleet vehicles for the first time ever. ACTS will begin licensing the technology to interested parties and a product equipped with the breath technology will be made available in late 2021 to any existing fleet or company that wants to outfit it into their vehicles – whether it be transportation vehicles, government fleets, rental cars, transportation vehicles, trucking companies, etc. This system is designed for fleet operators implementing a zero-tolerance alcohol policy for their drivers. Moreover, in 2021, the program announced the largest trial deployment of the driver alcohol detection system for safety technology to date, through a new trial deployment with truckload carrier Schneider. The pilot will help generate hundreds of thousands of real-world operating miles needed to commercialize fully passive vehicle-integrated breath technology — marking a new milestone toward the widespread deployment of the Driver Alcohol Detection System for Safety technology. Key features of the study • This report provides an in-depth analysis of the global alcohol breathalyzer and drug testing equipment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global alcohol breathalyzer and drug testing equipment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Dragerwerk AG & Co. KGaA, Quest Products, Inc., Intoximeters, Lion Laboratories Ltd., C4 Development Ltd., Alere, Inc., Lifeloc Technologies, BACtrack, Securetec Detektions-Systeme AG, and Andatech Private Ltd. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global alcohol breathalyzer and drug testing equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alcohol breathalyzer and drug testing equipment market Market Segmentation • Equipment Type Insights (Revenue, US$ Mn, 2026 - 2033) o Alcosensor (Fuel Cells) o Breathalyzer (Semiconductor) o Chromatographic Instruments o Hair Testing Devices (Kits) o Immuno Assay Analyzers o Intoxilyzer (IR) o Oral Fluid Testing Devices (Saliva) o Urine Testing Devices (Kits, Cassettes, Cups, and Dips) • Application Insights (Revenue, US$ Mn, 2026 - 2033) o Alcohol Detection o Drug Detection • End User Insights (Revenue, US$ Mn, 2026 - 2033) o Federal Departments o Hospitals o Private Sectors o Rehabilitation Centers • Regional Insights (Revenue, US$ Mn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  North Africa  Central Africa  South Africa • Key Players Insights o Dragerwerk AG & Co. KGaA o Quest Products, Inc. o Intoximeters o Lion Laboratories Ltd. o C4 Development Ltd. o Alere, Inc. o Lifeloc Technologies o BACtrack o Securetec Detektions-Systeme AG o Andatech Private Ltd.